Recent advances in CDC42 subfamily inhibition and therapeutic potential

57

Recent advances in CDC42 subfamily inhibition and therapeutic potential

Tags:

Previous Article

Metabolic dysfunction from heat stress via skin-hypothalamus axis

Inhibiting CDC42 subfamily to treat diseases

Related Posts

Tau and neuroinfammation in Alzheimer’s disease: interplay mechanisms and clinical translation

Tau and neuroinfammation in Alzheimer’s disease: interp...

152

A μ-opioid receptor superagonist analgesic with minimal adverse effects

A μ-opioid receptor superagonist analgesic with minimal...

119

A probabilistic histological atlas of the human brain for MRI segmentation

A probabilistic histological atlas of the human brain f...

67